• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性气道疾病急性加重期的治疗——阿莫西林与环丙沙星的比较

Treatment of acute exacerbations of chronic obstructive airways disease--a comparison of amoxycillin and ciprofloxacin.

作者信息

Basran G S, Joseph J, Abbas A M, Hughes C, Tillotson G S

机构信息

Rotherham District General Hospital, Rotherham, UK.

出版信息

J Antimicrob Chemother. 1990 Dec;26 Suppl F:19-24. doi: 10.1093/jac/26.suppl_f.19.

DOI:10.1093/jac/26.suppl_f.19
PMID:2292540
Abstract

Ciprofloxacin and amoxycillin were compared in the treatment of acute exacerbations of chronic obstructive airways disease. One hundred and forty patients were evaluable for overall outcome: 60 patients' sputum specimens yielded positive bacteriological cultures. The predominant pathogens were Haemophilus influenzae (43.3%) and Streptococcus pneumoniae (25.0%). Both regimens were safe and produced few adverse effects. An independent observer judged ciprofloxacin to produce a 91.8% success rate (complete success 21.9%; partial success 69.9%) whilst a 73.1% rate (complete success 10.4%; partial success 62.7%) was seen with amoxycillin.

摘要

对环丙沙星和阿莫西林治疗慢性阻塞性气道疾病急性加重期的疗效进行了比较。140例患者可对总体结果进行评估:60例患者的痰标本细菌培养呈阳性。主要病原体为流感嗜血杆菌(43.3%)和肺炎链球菌(25.0%)。两种治疗方案均安全,不良反应少。一名独立观察者判定环丙沙星的成功率为91.8%(完全成功21.9%;部分成功69.9%),而阿莫西林的成功率为73.1%(完全成功10.4%;部分成功62.7%)。

相似文献

1
Treatment of acute exacerbations of chronic obstructive airways disease--a comparison of amoxycillin and ciprofloxacin.慢性阻塞性气道疾病急性加重期的治疗——阿莫西林与环丙沙星的比较
J Antimicrob Chemother. 1990 Dec;26 Suppl F:19-24. doi: 10.1093/jac/26.suppl_f.19.
2
Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study.司帕沙星治疗慢性阻塞性肺疾病急性加重期的比较安全性和疗效:一项双盲、随机、平行、多中心研究。
J Antimicrob Chemother. 1996 May;37 Suppl A:93-104. doi: 10.1093/jac/37.suppl_a.93.
3
Comparison of amoxycillin/clavulanate with amoxycillin in children and adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae.阿莫西林/克拉维酸与阿莫西林在患有慢性阻塞性肺疾病并感染流感嗜血杆菌的儿童及成人中的比较。
Scand J Infect Dis. 1988;20(5):517-24. doi: 10.3109/00365548809032500.
4
Comparison of oral ciprofloxacin and amoxycillin in treating infective exacerbations of bronchiectasis in Hong Kong.口服环丙沙星与阿莫西林治疗香港支气管扩张症感染性加重的比较。
Chemotherapy. 1996 Mar-Apr;42(2):150-6. doi: 10.1159/000239435.
5
Controlled prospective study of oral amoxycillin/clavulanate vs ciprofloxacin in acute exacerbations of chronic bronchitis.
J Antimicrob Chemother. 1989 Nov;24 Suppl B:185-93. doi: 10.1093/jac/24.suppl_b.185.
6
Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis.
J Antimicrob Chemother. 1987 Mar;19(3):373-83. doi: 10.1093/jac/19.3.373.
7
Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin.环丙沙星与阿莫西林相比在呼吸道感染患者中的疗效和安全性。
J Antimicrob Chemother. 1986 Nov;18 Suppl D:133-8. doi: 10.1093/jac/18.supplement_d.133.
8
A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis.低剂量氧氟沙星与阿莫西林/克拉维酸治疗慢性支气管炎急性加重期的双盲对照研究
J Antimicrob Chemother. 1990 Nov;26 Suppl D:75-81. doi: 10.1093/jac/26.suppl_d.75.
9
Ciprofloxacin in acute exacerbations of chronic bronchitis.环丙沙星用于慢性支气管炎急性加重期
J Antimicrob Chemother. 1986 Sep;18(3):407-13. doi: 10.1093/jac/18.3.407.
10
Modulation of biofilm of strains isolated from patients with chronic obstructive pulmonary disease by levofloxacin, moxifloxacin, ciprofloxacin, amoxicillin/clavulanic acid and ceftriaxone.左氧氟沙星、莫西沙星、环丙沙星、阿莫西林/克拉维酸和头孢曲松对慢性阻塞性肺疾病患者分离株生物膜的调节。
Int J Immunopathol Pharmacol. 2011 Oct-Dec;24(4):1027-35. doi: 10.1177/039463201102400420.

引用本文的文献

1
Airway infection.气道感染
Infect Dis Clin North Am. 1998 Sep;12(3):671-88. doi: 10.1016/s0891-5520(05)70204-x.
2
Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.环丙沙星。对其药理学、治疗效果及耐受性的最新综述。
Drugs. 1996 Jun;51(6):1019-74. doi: 10.2165/00003495-199651060-00010.
3
Antibiotics in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的抗生素
BMJ. 1994 Apr 2;308(6933):871-2. doi: 10.1136/bmj.308.6933.871.
4
Fluoroquinolones in upper respiratory tract infections.氟喹诺酮类药物在上呼吸道感染中的应用
BMJ. 1994 Mar 5;308(6929):657-8. doi: 10.1136/bmj.308.6929.657c.
5
Fluoroquinolones in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的氟喹诺酮类药物。
BMJ. 1994 May 28;308(6941):1437. doi: 10.1136/bmj.308.6941.1437a.
6
Epidemiology and treatment of chronic bronchitis and its exacerbations.慢性支气管炎及其急性加重的流行病学与治疗
Chest. 1995 Aug;108(2 Suppl):43S-52S. doi: 10.1378/chest.108.2_supplement.43s.
7
Antibiotic resistance in common acute respiratory pathogens.常见急性呼吸道病原体中的抗生素耐药性。
Thorax. 1995 May;50(5):481-3. doi: 10.1136/thx.50.5.481.
8
Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.全科医疗中慢性阻塞性肺疾病患者急性加重期使用抗生素治疗期间症状、呼气峰值流速及痰液菌群的变化
Thorax. 1995 Jul;50(7):758-63. doi: 10.1136/thx.50.7.758.
9
Rufloxacin once daily in acute exacerbations of chronic bronchitis.慢性支气管炎急性加重期每日一次服用芦氟沙星。
Infection. 1991 Jul-Aug;19(4):297-300. doi: 10.1007/BF01644971.